TP53 and renal cell carcinoma: As listed in Table 2, there were significant decreases in P53 expression levels in pediatric patients with WT and hypernephroma who relapsed after one year of chemotherapy compared to their levels before chemotherapy (p = 0.001 and 0.002, respectively).